Drugs Made In America Acquisition II Corp. disclosed that its sponsor made improper withdrawals from the working capital account between September 26, 2025, and December 31, 2025. The board confirmed the irregularities did not affect the Trust Account, which holds approximately $507,841,957 as of March 6, 2026.
Key takeaways
Sponsor made improper withdrawals (Irregularities) from working capital account between IPO completion on September 26, 2025 and December 31, 2025
Board confirmed Irregularities did not extend to Trust Account
Trust Account balance confirmed at approximately $507,841,957 as of March 6, 2026
Initial public offering completed on September 26, 2025